Equibles does not estimate personal net worth.
Get an email with a short summary when Vertex Pharmaceuticals Inc publishes a filing, an earnings call transcript or a press release.
Get VRTX alertsVertex Pharmaceuticals Inc reported in an 8-K filed February 10, 2025 that Duncan J. McKechnie was appointed Chief Commercial Officer, effective July 1, 2025. Duncan J. McKechnie has spoken on 1 earnings call across 1 company, most recently for Vertex Pharmaceuticals Inc on November 2, 2026. Vertex Pharmaceuticals Inc is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Vertex Pharmaceuticals Inc includes Dr. Reshma Kewalramani (CEO), Reshma Kewalramani (CEO and Board Member), Dr. Jeffrey M. Leiden (Chairman) and 7 others.
“the appointment of Duncan J. McKechnie as Chief Commercial Officer of the Company.”
“Our commercial story continues to be one of excellence in launch execution across CF, heme, pain, and most recently, rare endocrinology.”
2025-07-01–present
Biotechnology · Healthcare
